✦ LIBER ✦

Predicting everolimus/letrozole treatment efficacy in patients with advanced or recurrent endometrial cancer: A biomarker study

✍ Scribed by Jiang, Y.; Slomovitz, B.M.; Zhang, Q.; Amin, Y.; Broaddus, R.; Coleman, R.L.; Lu, K.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting everolimus treatment efficacy

✍ TrÃ©dan, Olivier; Treilleux, Isabelle; Wang, Qing; Gane, Nicolas; Pissaloux, Dan 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 260 KB

Paclitaxel and carboplatin in the treatm

✍ M.A. SOVAK; J. DUPONT; M.L. HENSLEY; N. ISHILL; S. GERST; N. ABU-RUSTUM; S. ANDE 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

The activity of letrozole in patients wi

✍ B. B. Y. Ma; A. Oza; E. Eisenhauer; G. Stanimir; M. Carey; W. Chapman; E. Latta; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

A phase I clinical trial of the mTOR inh

✍ M. Abu-Khalaf; A. Santin; E. Ratner; D. Silasi; K. ElSahwi; L. Baker; M. Luther; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Phase II study of carboplatin in patient

✍ F.H van Wijk; C Lhommé; G Bolis; V Scotto di Palumbo; S Tumolo; M Nooij; C.F de 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

The oral mTOR inhibitor RAD001 (everolim

✍ Ahmad Awada; Fatima Cardoso; Christel Fontaine; Luc Dirix; Jacques De Grève; Chr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 175 KB